Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections
- PMID: 31207286
- DOI: 10.1016/j.micinf.2019.06.002
Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections
Abstract
Protein ADP-ribosylation is a reversible post-translational modification, which alters protein activity, localization, interactome or stability, leading to perturbation of cell signaling. This review summarizes the emerging data indicating that host cell ADP-ribosylating enzymes, poly(ADP-ribose) polymerases (PARPs), influence the course of a bacterial infection, in parallel to ADP-ribosylating bacterial toxins. Host cell PARP targeting could be an efficient therapeutic approach to treat certain bacterial infections, possibly by repurposing the approved or clinical trial PARP inhibitors developed for cancer therapy.
Keywords: ADP-ribosylation; ARTD; Bacteria; Immunity; Infection; PARP.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
Small-Molecule Inhibitors of PARPs: From Tools for Investigating ADP-Ribosylation to Therapeutics.Curr Top Microbiol Immunol. 2019;420:211-231. doi: 10.1007/82_2018_137. Curr Top Microbiol Immunol. 2019. PMID: 30242511 Free PMC article. Review.
-
Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity.Microbiol Mol Biol Rev. 2018 Dec 19;83(1):e00038-18. doi: 10.1128/MMBR.00038-18. Print 2019 Mar. Microbiol Mol Biol Rev. 2018. PMID: 30567936 Free PMC article. Review.
-
Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.J Biol Chem. 2020 Dec 25;295(52):17986-17996. doi: 10.1074/jbc.RA120.015138. Epub 2020 Oct 13. J Biol Chem. 2020. PMID: 33051211 Free PMC article.
-
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.Biochem Pharmacol. 2019 Sep;167:97-106. doi: 10.1016/j.bcp.2019.05.007. Epub 2019 May 7. Biochem Pharmacol. 2019. PMID: 31075269
-
The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.Genes Dev. 2020 Mar 1;34(5-6):341-359. doi: 10.1101/gad.334425.119. Epub 2020 Feb 6. Genes Dev. 2020. PMID: 32029454 Free PMC article. Review.
Cited by
-
Exotoxin-Targeted Drug Modalities as Antibiotic Alternatives.ACS Infect Dis. 2022 Mar 11;8(3):433-456. doi: 10.1021/acsinfecdis.1c00296. Epub 2022 Jan 31. ACS Infect Dis. 2022. PMID: 35099182 Free PMC article. Review.
-
Roles of ADP-Ribosylation during Infection Establishment by Trypanosomatidae Parasites.Pathogens. 2023 May 12;12(5):708. doi: 10.3390/pathogens12050708. Pathogens. 2023. PMID: 37242378 Free PMC article. Review.
-
Identification of Poly(ADP-ribose) Polymerase 9 (PARP9) as a Potent Suppressor for Mycobacterium tuberculosis Infection.Phenomics. 2023 Sep 4;4(2):158-170. doi: 10.1007/s43657-023-00112-2. eCollection 2024 Apr. Phenomics. 2023. PMID: 38884060 Free PMC article.
-
NAD+-consuming enzymes in immune defense against viral infection.Biochem J. 2021 Dec 10;478(23):4071-4092. doi: 10.1042/BCJ20210181. Biochem J. 2021. PMID: 34871367 Free PMC article. Review.
-
Tankyrase inhibitors hinder Trypanosoma cruzi infection by altering host-cell signalling pathways.Parasitology. 2021 Nov;148(13):1680-1690. doi: 10.1017/S0031182021001402. Epub 2021 Aug 12. Parasitology. 2021. PMID: 35060470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical